These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10655270)

  • 1. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation.
    Brandhagen DJ; Alvarez W; Therneau TM; Kruckeberg KE; Thibodeau SN; Ludwig J; Porayko MK
    Hepatology; 2000 Feb; 31(2):456-60. PubMed ID: 10655270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
    Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation.
    Stuart KA; Fletcher LM; Clouston AD; Lynch SV; Purdie DM; Kerlin P; Crawford DH
    Hepatology; 2000 Dec; 32(6):1200-7. PubMed ID: 11093725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for hereditary hemochromatosis.
    Brandhagen DJ
    Liver Transpl; 2001 Aug; 7(8):663-72. PubMed ID: 11510009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
    Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
    Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
    Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
    Nash S; Marconi S; Sikorska K; Naeem R; Nash G
    Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary hemochromatosis in liver transplantation.
    Fiel MI; Schiano TD; Bodenheimer HC; Thung SN; King TW; Varma CR; Miller CM; Brunt EM; Starnes S; Prass C; Wolff RK; Bacon BR
    Liver Transpl Surg; 1999 Jan; 5(1):50-6. PubMed ID: 9873093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
    Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical significance of HFE gene mutations in patients with iron overload.
    Brandhagen DJ; Fairbanks VF; Baldus WP; Smith CI; Kruckeberg KE; Schaid DJ; Thibodeau SN
    Am J Gastroenterol; 2000 Oct; 95(10):2910-4. PubMed ID: 11051367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis.
    Eng SC; Taylor SL; Reyes V; Raaka S; Berger J; Kowdley KV
    Liver Int; 2005 Jun; 25(3):513-7. PubMed ID: 15910487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between HFE mutations and mild iron-overload expression.
    Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
    Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
    Phatak PD; Barton JC
    Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iron in the era of molecular biology].
    Deugnier Y; Moirand R; Brissot P; David V
    Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological evaluation of iron in liver biopsies: relationship to HFE mutations.
    Brunt EM; Olynyk JK; Britton RS; Janney CG; Di Bisceglie AM; Bacon BR
    Am J Gastroenterol; 2000 Jul; 95(7):1788-93. PubMed ID: 10925986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
    Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
    Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.